|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1401 I Street, NW, Suite 330 |
Address2 | |
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 308536-12
|
||||||||
|
6. House ID# 384000000
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: William Franco, Sr. Director Government Affairs and Policy |
Date | 01/15/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Physician Payments Sunshine provision of H.R. 3200 America's Affordable Health Choices Act of 2009
Physician Payments Sunshine provision of Affordable Health Care for America Act (H.R. 3962)- House
Physician Payments Sunshine provision of Patient Protection and Affordable Care Act (H.R. 3590)-Senate
FDA Risk Evaulation Mitigation Strategies (REMS)
Drug Safety Communications
Drug importation issues in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
William |
Franco |
|
|
|
Craig |
Burton |
|
Depty. Asst. Sec. for Legislation-HHS (04-08) |
|
Craig |
Burton |
|
Staff, Senate HELP Cmte. (1998-04) |
|
Craig |
Burton |
|
Staff, Senator Bill Frist (1998-04) |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Provisions related to comparative effectiveness reserach in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
William |
Franco |
|
|
|
Craig |
Burton |
|
Dep. Asst. Sec. for Legislation- HHS (04-08) |
|
Craig |
Burton |
|
Staff, Senate HELP Cmte (1998-04) |
|
Craig |
Burton |
|
Staff, Senator Bill Frist (1998-04) |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Provisions related to the expansion of Medicaid rebates in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
Provisions related to the expansion of Medicaid eligibility in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
Provisions related to Medicare Part D in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
William |
Franco |
|
|
|
Craig |
Burton |
|
Dep. Asst. Sec. for Legislation- HHS (04-08) |
|
Craig |
Burton |
|
Staff, Senate HELP Cmte. (1998-04) |
|
Craig |
Burton |
|
Staff, Senator Bill Frist (1998-04) |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Exclusivity, damanges and estoppel provisions in the Patent Reform Act of 2009 (S. 515, H.R. 1260)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
William |
Franco |
|
|
|
Craig |
Burton |
|
Dep. Asst. Sec. for Legislation- HHS (04-08) |
|
Craig |
Burton |
|
Staff, Senate HELP (1998-04) |
|
Craig |
Burton |
|
Staff, Senator Bill Frist (1998-04) |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Comparative effectiveness provisions in the American Recovery and Reinvestment Act (H.R. 1)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
William |
Franco |
|
|
|
Craig |
Burton |
|
Dep. Asst. Sec. for Legislation (04-08) |
|
Craig |
Burton |
|
Staff, Senate HELP Cmte. (1998-04) |
|
Craig |
Burton |
|
Staff, Senator Bill Frist, (1998-04) |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Chronic disease and diabetes care related provisions in Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
Provisions related to comparative effectiveness reserach and reimbursement in the Affordable Health Care for America Act (H.R. 3962)- House and the Patient Protection and Affordable Care Act (H.R. 3590)-Senate
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
William |
Franco |
|
|
|
Craig |
Burton |
|
Dep. Asst. Sec. for Legislation (04-08) |
|
Craig |
Burton |
|
Staff, Senate HELP Cmte. (1998-04) |
|
Craig |
Burton |
|
Staff, Senator Bill Frist (1998-04) |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |